Literature DB >> 18957605

Antibacterial activity of Cyt1Aa from Bacillus thuringiensis subsp. israelensis.

Rivka Cahan1, Hen Friman2,1, Yeshayahu Nitzan2.   

Abstract

Cyt1Aa is a delta-endotoxin protein that is produced by Bacillus thuringiensis subsp. israelensis. It is a membrane pore-forming toxin that is lethal to insect larvae and is broadly cytolytic to vertebrate as well as invertebrate cells. Cyt1Aa is produced as a protoxin of 27 kDa. Proteolytic activation results in a reduction of the molecular mass to approximately 23-24 kDa and a threefold increase in activity. In this research, Cyt1Aa crystals were purified from B. thuringiensis IPS78/11 harbouring the expression vector pHT-cyAp20. The activity of the activated form of Cyt1Aa (23-24 kDa) was examined on a pathogenic strain of the Gram-negative Escherichia coli and the Gram-positive species Staphylococcus aureus. The Cyt1Aa minimal inhibitory concentration for E. coli and S. aureus was 1.25 and 5 microg ml(-1), respectively. Cyt1Aa was found to be bactericidal for E. coli, whereas it was bacteriostatic for S. aureus. Furthermore, Cyt1Aa increased the lethal effect when acting in combination with antibiotics. The association of Cyt1Aa with cells of these two bacteria was demonstrated by Western blot analysis using antibodies against the whole delta-endotoxin crystal. Scanning electron microscopy displayed damage to Cyt1Aa-treated cells. Ion imbalance due to damage of the cell walls and membranes was confirmed by X-ray microanalysis. These experiments show that Cyt1Aa has an antibacterial effect on pathogenic species and demonstrate, apparently for the first time, that exogenous Cyt1Aa has a bactericidal effect upon Gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957605     DOI: 10.1099/mic.0.2008/020784-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  6 in total

1.  C-terminal amino acids of alpha-melanocyte-stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus.

Authors:  Madhuri Singh; Kasturi Mukhopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  Expression in Escherichia coli of the native cyt1Aa from Bacillus thuringiensis subsp. israelensis.

Authors:  Vladislav Sazhenskiy; Arieh Zaritsky; Mark Itsko
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

Review 3.  Bacillus thuringiensis subsp. israelensis and its dipteran-specific toxins.

Authors:  Eitan Ben-Dov
Journal:  Toxins (Basel)       Date:  2014-03-28       Impact factor: 4.546

4.  Cholesterol Increases Lipid Binding Rate and Changes Binding Behavior of Bacillus thuringiensis Cytolytic Protein.

Authors:  Sudarat Tharad; Öykü Üzülmez; Boonhiang Promdonkoy; José L Toca-Herrera
Journal:  Int J Mol Sci       Date:  2018-11-30       Impact factor: 5.923

5.  Bacillus thuringiensis Cyt2Aa2 toxin disrupts cell membranes by forming large protein aggregates.

Authors:  Sudarat Tharad; José L Toca-Herrera; Boonhiang Promdonkoy; Chartchai Krittanai
Journal:  Biosci Rep       Date:  2016-10-14       Impact factor: 3.840

6.  Protein-Lipid Interaction of Cytolytic Toxin Cyt2Aa2 on Model Lipid Bilayers of Erythrocyte Cell Membrane.

Authors:  Sudarat Tharad; Boonhiang Promdonkoy; José L Toca-Herrera
Journal:  Toxins (Basel)       Date:  2020-04-03       Impact factor: 5.075

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.